Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patientsJohn Munkhaugen, Einar Husebye, Lars Gullestad et al.|European Journal of Preventive Cardiology|2017Cited by 47
The prevalence and predictors of elevated C-reactive protein after a coronary heart disease eventJohn Munkhaugen, Lars Gullestad, Jan Erik Otterstad et al.|European Journal of Preventive Cardiology|2018Cited by 37
Unfavourable risk factor control after coronary events in routine clinical practiceElise Sverre, John Munkhaugen, Kari Peersen et al.|BMC Cardiovascular Disorders|2017Cited by 31
The role of medical and psychosocial factors for unfavourable coronary risk factor controlJohn Munkhaugen, Toril Dammen, Elise Sverre et al.|Scandinavian Cardiovascular Journal|2015Cited by 28
A Method for Direct Monitoring of Atorvastatin Adherence in Cardiovascular Disease Prevention: Quantification of the Total Exposure to Parent Drug and Major Metabolites Using 2-Channel Chromatography and Tandem Mass SpectrometryNils Tore Vethe, Stein Bergan, John Munkhaugen et al.|Therapeutic Drug Monitoring|2018Cited by 25